Diagnostic Imaging's Weekly Scan: November 24 — November 30

In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

Emerging research from the RSNA conference suggests that two-dimensional mammography would only detect 41 percent of detectable breast cancer.

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

In a multicenter study involving over 747,000 women who had mammography screening, those who paid for AI-enhanced screening had a 21 percent higher recall rate and a 15 percent higher positive predictive value (PPV) for breast cancer, according to research presented at the Radiological Society of North America (RSNA) conference.

The computed tomography device reportedly offers enhanced post-processing of images as well as bolstered image reconstruction capabilities with an 80 percent reduction in radiation dosing.